FUSTAR PHARMACEUTICALS ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON TUESDAY, MARCH 26, 2024, AT WHICH TIME THE COMPANY AND ITS SUBSIDIARIES WILL CONSIDER AND APPROVE THE ANNUAL RESULTS REPORT FOR THE YEAR ENDED DECEMBER 31, 2023, AND THE PROPOSED FINAL DIVIDEND (IF ANY) WILL BE DISCUSSED. Other matters will be dealt with at this meeting. The members of the Board of Directors include Executive Directors Wu Yifang, Wang Kechin, Guan Xiaoxin, Wen De Yung, Non-Executive Directors Chen Qiyu, Yao Fang, Xu Xiaoliang, Pan Donghui, and Independent Non-Executive Directors Li Ling, Tung Guan Liang, Wang Quan, Yu Zishan.

FUSTAR PHARMACEUTICALS ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON TUESDAY, MARCH 26, 2024, AT WHICH TIME THE COMPANY AND ITS SUBSIDIARIES WILL CONSIDER AND APPROVE THE ANNUAL RESULTS REPORT FOR THE YEAR ENDED DECEMBER 31, 2023, AND THE PROPOSED FINAL DIVIDEND (IF ANY) WILL BE DISCUSSED. Other matters will be dealt with at this meeting. The members of the Board of Directors include Executive Directors Wu Yifang, Wang Kechin, Guan Xiaoxin, Wen De Yung, Non-Executive Directors Chen Qiyu, Yao Fang, Xu Xiaoliang, Pan Donghui, and Independent Non-Executive Directors Li Ling, Tung Guan Liang, Wang Quan, Yu Zishan.